AbbVie
AbbVie is seeking a highly motivated Scientist II to drive the development of peptide programs from pre-clinical through clinical stages. The role involves developing robust synthetic processes for peptide assets and other synthetic molecule modalities while participating in cross-functional project teams. The position requires strong scientific leadership, effective communication, and the ability to resolve key project hurdles through independent laboratory research and method development.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.
Scientist, Chemistry
Bristol Myers Squibb
Research or Senior Scientist - Peptide Chemistry
City of Winnipeg
Senior Scientist I/II, Peptide Early Phase Analytical R&D
AbbVie
Scientist, Peptide Process Chemistry
Eli Lilly and Company
Scientific Director - Sustainable Peptide Process Chemistry – SMDD
Eli Lilly and Company
Director - Head of Drug Substance & Analytical Development
Zealand Pharma